Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
ABOUT THIS PAGE
62
PharmaCompass offers a list of Lurtotecan API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lurtotecan manufacturer or Lurtotecan supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lurtotecan manufacturer or Lurtotecan supplier.
PharmaCompass also assists you with knowing the Lurtotecan API Price utilized in the formulation of products. Lurtotecan API Price is not always fixed or binding as the Lurtotecan Price is obtained through a variety of data sources. The Lurtotecan Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Lurtotecan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lurtotecan, including repackagers and relabelers. The FDA regulates Lurtotecan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lurtotecan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Lurtotecan supplier is an individual or a company that provides Lurtotecan active pharmaceutical ingredient (API) or Lurtotecan finished formulations upon request. The Lurtotecan suppliers may include Lurtotecan API manufacturers, exporters, distributors and traders.
click here to find a list of Lurtotecan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Lurtotecan DMF (Drug Master File) is a document detailing the whole manufacturing process of Lurtotecan active pharmaceutical ingredient (API) in detail. Different forms of Lurtotecan DMFs exist exist since differing nations have different regulations, such as Lurtotecan USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Lurtotecan DMF submitted to regulatory agencies in the US is known as a USDMF. Lurtotecan USDMF includes data on Lurtotecan's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Lurtotecan USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Lurtotecan suppliers with USDMF on PharmaCompass.
Lurtotecan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lurtotecan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lurtotecan GMP manufacturer or Lurtotecan GMP API supplier for your needs.
A Lurtotecan CoA (Certificate of Analysis) is a formal document that attests to Lurtotecan's compliance with Lurtotecan specifications and serves as a tool for batch-level quality control.
Lurtotecan CoA mostly includes findings from lab analyses of a specific batch. For each Lurtotecan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lurtotecan may be tested according to a variety of international standards, such as European Pharmacopoeia (Lurtotecan EP), Lurtotecan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lurtotecan USP).
